A future for CD3 antibodies in immunotherapy of type 1 diabetes

Overview of attention for article published in Diabetologia, January 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 50,182 followers.

RT @DiabetologiaJnl: A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlSv0l #toptweet

A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlSv0l #toptweet

RT @DiabetologiaJnl: A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlATBL

RT @DiabetologiaJnl: A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlATBL

RT @DiabetologiaJnl: A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlATBL

Un avenir pour les anticorps anti-CD3 en immunothérapie du diabète de type 1

A future for CD3 antibodies in immunotherapy of type 1 diabetes https://t.co/21JOtlATBL

Where do we go from here? CD3 antibodies in immunotherapy #T1D https://t.co/hUeQgxa33z